Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2015
In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancerSimone U Dalm, John W M Martens, Anieta M Sieuwerts, et al.
Plos One|January 21, 2017
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast CancerSimone U Dalm, Willemijne A M E Schrijver, Anieta M Sieuwerts, et al.
Theranostics|January 2, 2016
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical StudiesKristell L S Chatalic, Mark Konijnenberg, Julie Nonnekens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2021
GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve PatientsIngrid L Bakker, Alida C Fröberg, Martijn B Busstra, et al.
EJNMMI Research|May 10, 2021
Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small moleculesMarcus C M Stroet, Bianca M Dijkstra, Sebastiaan E Dulfer, et al.
Seminars in Nuclear Medicine|April 20, 2002
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experienceRoelf Valkema, Marion De Jong, Willem H Bakker, et al.
Aging Cell|November 3, 2009
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in miceJames R Mitchell, Mariëlle Verweij, Karl Brand, et al.
Endokrynologia Polska|June 30, 2025
Calcitonin and procalcitonin measurement after cholecystokinin-2/gastrin receptor agonist stimulation in patients with advanced medullary thyroid cancer: results from the GRAN-T-MTC studyMałgorzata Trofimiuk-Müldner, Katica Bajuk Studen, Paola Anna Erba, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 17, 2017
213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer XenograftsJulie Nonnekens, Kristell L S Chatalic, Janneke D M Molkenboer-Kuenen, et al.
Diabetologia|February 4, 2014
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendinMaarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, et al.
Pageof 20